Chikungunya fever.

Authors :: Bartholomeeusen K
Daniel M
LaBeaud DA
Gasque P
Peeling RW
Stephenson KE
Ng LFP
Ariën KK
Source :: Nature reviews. Disease primers [Nat Rev Dis Primers] 2023 Apr 06; Vol. 9 (1), pp. 17. Date of Electronic Publication: 2023 Apr 06.
Publication Year :: 2023
Abstract: Chikungunya virus is widespread throughout the tropics, where it causes recurrent outbreaks of chikungunya fever. In recent years, outbreaks have afflicted populations in East and Central Africa, South America and Southeast Asia. The virus is transmitted by Aedes aegypti and Aedes albopictus mosquitoes. Chikungunya fever is characterized by severe arthralgia and myalgia that can persist for years and have considerable detrimental effects on health, quality of life and economic productivity. The effects of climate change as well as increased globalization of commerce and travel have led to growth of the habitat of Aedes mosquitoes. As a result, increasing numbers of people will be at risk of chikungunya fever in the coming years. In the absence of specific antiviral treatments and with vaccines still in development, surveillance and vector control are essential to suppress re-emergence and epidemics.<br /> (© 2023. Springer Nature Limited.)